Lou Gehrig’s Disease (ALS): Progress and Promise in Stem Cell Research
CIRM has funded the ALS Disease Team led by scientists at who aim to bring a human embryonic stem cell based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years from the onset of symptoms. For more information visit CIRM’s ALS disease fact sheet and The ALS Association website.